R. Guermaz

497 total citations
12 papers, 41 citations indexed

About

R. Guermaz is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, R. Guermaz has authored 12 papers receiving a total of 41 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Epidemiology. Recurrent topics in R. Guermaz's work include Vasculitis and related conditions (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). R. Guermaz is often cited by papers focused on Vasculitis and related conditions (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). R. Guermaz collaborates with scholars based in Algeria, France and Nepal. R. Guermaz's co-authors include S. Zekri, Myriam Ammi, J.-P. Laroche and Soraya Mezouar and has published in prestigious journals such as SHILAP Revista de lepidopterología, La Revue de Médecine Interne and Annales de Cardiologie et d Angéiologie.

In The Last Decade

R. Guermaz

10 papers receiving 39 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Guermaz Algeria	4	16	16	14	13	8	12	41
Éamon P McCarron United Kingdom	5	29 1.8×	9 0.6×	15 1.1×	5 0.4×	26 3.3×	20	86
Halldóra Björnsdóttir Iceland	3	7 0.4×	7 0.4×	31 2.2×	9 0.7×	15 1.9×	3	51
Javier Castell Spain	3	13 0.8×	52 3.3×	8 0.6×	11 0.8×	6 0.8×	4	84
Yingchai Zhang China	5	34 2.1×	9 0.6×	11 0.8×	8 0.6×	6 0.8×	7	78
Matija Cevc Slovenia	4	13 0.8×	5 0.3×	25 1.8×	17 1.3×	41 5.1×	10	64
Patrícia Marques‐Alves Portugal	6	14 0.9×	13 0.8×	65 4.6×	9 0.7×	5 0.6×	19	85
Laila Bendriss Morocco	4	9 0.6×	13 0.8×	24 1.7×	5 0.4×	5 0.6×	12	42
Stefania Locatelli Italy	4	18 1.1×	8 0.5×	22 1.6×	4 0.3×	7 0.9×	6	58
Ana Cvetković Serbia	4	14 0.9×	6 0.4×	5 0.4×	6 0.5×	13 1.6×	12	31
S Kosasih Malaysia	3	8 0.5×	20 1.3×	4 0.3×	5 0.4×	9 1.1×	6	30

Countries citing papers authored by R. Guermaz

Since Specialization

Citations

This map shows the geographic impact of R. Guermaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Guermaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Guermaz more than expected).

Fields of papers citing papers by R. Guermaz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Guermaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Guermaz. The network helps show where R. Guermaz may publish in the future.

Co-authorship network of co-authors of R. Guermaz

This figure shows the co-authorship network connecting the top 25 collaborators of R. Guermaz. A scholar is included among the top collaborators of R. Guermaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Guermaz. R. Guermaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Guermaz, R., et al.. (2023). Ankle systolic pressure index in non-diabetic non-alcoholic fatty liver disease: A case-control study. JMV-Journal de Médecine Vasculaire. 48(5-6). 154–162. 2 indexed citations

2.

Guermaz, R., et al.. (2021). Subclinical atherosclerosis and arterial stiffness in nonalcoholic fatty liver disease: A case-control study in Algerian population. JMV-Journal de Médecine Vasculaire. 46(3). 129–138. 11 indexed citations

3.

Guermaz, R., et al.. (2020). L’index de pression systolique et la Non Alcoholic Fatty Liver Disease (NAFLD) : une étude cas -témoins. JMV-Journal de Médecine Vasculaire. 45. S41–S41. 1 indexed citations

4.

Guermaz, R., et al.. (2020). Pre-diabetes and NAFLD; A study of an Algerian population sample. SHILAP Revista de lepidopterología. 1(3-4). 100060–100060. 4 indexed citations

5.

Guermaz, R., et al.. (2019). Artérite de Takayasu et athérosclérose. JMV-Journal de Médecine Vasculaire. 44(5). 311–317. 9 indexed citations

6.

Guermaz, R., et al.. (2017). Accelerated Atherosclerosis in Takayasu Disease: Case-Control Study. 7(1). 12–24. 2 indexed citations

7.

Guermaz, R., et al.. (2017). L’hypertension artérielle au cours de la maladie de Takayasu : à propos d’une série monocentrique de 279 patients. Annales de Cardiologie et d Angéiologie. 66(3). 154–158. 7 indexed citations

8.

Ammi, Myriam, et al.. (2017). Manifestations cardiaques au cours de la maladie de Behçet : à propos de 3 observations. JMV-Journal de Médecine Vasculaire. 42(2). 115–116.

9.

Guermaz, R., et al.. (2015). Prophylaxie de la maladie thromboembolique veineuse chez les patients à risque hospitalisés en Algérie : étude PROMET. Journal des Maladies Vasculaires. 40(4). 240–247. 2 indexed citations

10.

Mezouar, Soraya, et al.. (2010). L’atteinte anévrysmale au cours de la maladie de Takayasu. Journal des Maladies Vasculaires. 35(5). 325–325. 1 indexed citations

11.

Guermaz, R., et al.. (2009). HTA et maladie de Takayasu. La Revue de Médecine Interne. 30. S328–S328. 1 indexed citations

12.

Guermaz, R., et al.. (2008). Diabète de type 2 en Algérie : poids actuel et à venir. La Revue de Médecine Interne. 29. S49–S50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact